[Ip-health] DHHS "very close" on march in decision
Sean Flynn
sean.flynn@cptech.org
Fri Mar 19 10:36:02 2004
Department of Health and Human Services
Public Health Service
National Institutes of Health
Office of Technology Transfer
National Institutes of Health
6011 Executive Boulevard
Rockville, MD 20852
March 12, 2004
Mr. James Love, President
And
Mr. Sean Flynn, Counsel
Essential Inventions, Inc.
P.O. Box 19367
Washington, D.C. 20036
Gentlemen:
Thank you for your letter of March 10 regarding your concerns about the
pricing of ritonavir and latanoprost. We would be happy to meet with
you to discuss the Bayh-Dole Act and how it is implemented by the
National Institutes of Health (NIH).
We expect our response to your petitions to be available very soon and I
would suggest we attempt to schedule a meeting after you have time to
review it. Please contact my Secretary Mary Martinez at (301) 594-7700
to assist you in scheduling.
Sincerely,
Mark L. Rohrbaugh, Ph.D., J.D.
Director, Office of Technology Transfer